We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.22B
AUM Growth
+$2.7B
Cap. Flow
+$3.76B
Cap. Flow %
89.24%
Top 10 Hldgs %
40.53%
Holding
623
New
593
Increased
5
Reduced
1
Closed
3

Top Buys

Rank Stock Value
1
OSH
Oak Street Health, Inc.
OSH
+$211M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$189M
3
UNVR
Univar Solutions Inc.
UNVR
+$175M
4
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$143M
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$137M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$196M
2
SGFY
Signify Health, Inc.
SGFY
+$161M
3
ONEM
1Life Healthcare
ONEM
+$141M
4
TGNA
TEGNA Inc
TGNA
+$46.6M

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.36%
3 Technology 18.59%
4 Industrials 5.57%
5 Real Estate 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NNN icon
276
NNN REIT
NNN
$9.02B
$2.24M 0.05%
+50,648
New +$2.31M
FNVT
277
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
$2.22M 0.05%
+212,681
New +$2.2M
BPMC
278
DELISTED
Blueprint Medicines
BPMC
$2.21M 0.05%
+49,233
New +$2.22M
DNAD
279
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$2.21M 0.05%
+216,014
New +$2.19M
KIDS icon
280
OrthoPediatrics
KIDS
$596M
$2.2M 0.05%
+49,646
New +$2.19M
CITE
281
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$2.2M 0.05%
+208,518
New +$2.18M
MRUS
282
DELISTED
Merus
MRUS
$2.12M 0.05%
+115,080
New +$2M
SPEC
283
DELISTED
Spectaire Holdings, Inc. Common Stock
SPEC
$2.11M 0.05%
+198,893
New +$2.08M
GMFI
284
DELISTED
Aetherium Acquisition Corp
GMFI
$2.1M 0.05%
+201,057
New +$2.07M
RCUS icon
285
Arcus Biosciences
RCUS
$3.61B
$2.09M 0.05%
+114,480
New +$2.19M
ORIC icon
286
Oric Pharmaceuticals
ORIC
$1.34B
$2.07M 0.05%
+362,707
New +$1.9M
NVDA icon
287
NVIDIA
NVDA
$5.3T
$2.03M 0.05%
+73,260
New +$1.59M
DYN icon
288
Dyne Therapeutics
DYN
$4.83B
$2.03M 0.05%
+176,601
New +$2.29M
MORN icon
289
Morningstar
MORN
$7.37B
$2.03M 0.05%
+10,000
New +$2.2M
MDT icon
290
Medtronic
MDT
$110B
$2.02M 0.05%
+25,000
New +$2.04M
AMD icon
291
Advanced Micro Devices
AMD
$799B
$2.01M 0.05%
+20,536
New +$1.67M
ESTA icon
292
Establishment Labs
ESTA
$2.33B
$1.98M 0.05%
+29,189
New +$2M
HLN icon
293
Haleon
HLN
$44.2B
$1.97M 0.05%
+241,662
New +$1.93M
VRNA
294
DELISTED
Verona Pharma
VRNA
$1.96M 0.05%
+97,572
New +$2.11M
FRBN
295
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
$1.95M 0.05%
+185,349
New +$1.93M
BLU
296
DELISTED
BELLUS Health Inc.
BLU
$1.95M 0.05%
+271,161
New +$2.1M
IRTC icon
297
iRhythm Holdings
IRTC
$4.21B
$1.95M 0.05%
+15,715
New +$1.7M
HCMA
298
DELISTED
HCM Acquisition Corp Class A Ordinary Shares
HCMA
$1.95M 0.05%
+185,349
New +$1.92M
KROS icon
299
Keros Therapeutics
KROS
$211M
$1.94M 0.05%
+45,484
New +$2.3M
WEL
300
DELISTED
Integrated Wellness Acquisition Corp
WEL
$1.92M 0.05%
+185,349
New +$1.93M
10 11
12
13 14

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 623 positions worth $4.22B, up 177% from $1.52B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor deployed $3.76B of net new capital in Q1 2023, opening 593 new positions and adding to 5 existing holdings. Its largest new stake was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Activision Blizzard, an estimated $196M trimmed.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited Signify Health, Inc. in Q1 2023, selling an estimated $161M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 593 new positions and closed 3 in Q1 2023.
  • UBS O'Connor's portfolio value rose 177% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.